Patent ID: 7329754

Claim:
A 2,5-diazabicyclo[2.2.1]heptane derivative represented by the general Formula I wherein R 1 represents hydrogen, an alkyl group, a cycloalkyl group, an alkenyl group or a benzyl group; and R 2 represents a 2-quinolinyl or a benzothiazolyl, which heterocyclic group is optionally substituted one or more times with substituents selected from the group consisting of alkyl, alkoxy, alkoxyalkyl, cycloalkyl, cycloalkoxy, alkoxycycloalkyl, cycloalkoxyalkoxy, cycloalkylalkyl, hydroxyalkoxy, alkenyl, alkoxyalkenyl, alkynyl, alkoxyalkynyl, alkenoxy, alkynoxy, alkylthio, alkenylthio, alkynylthio, alkylseleno, alkenylseleno, alkynylseleno, methylenedioxy, trifluoromethanesulfonyloxy, halogen, —OH, —CF 3 , —OCF 3 , —CN, amino, nitro, oxime, alkyloxime, acyloxime, or a group of the formula —(CO)R 3 , —COOR 3 , —O(CO)R 3 , —CONR 2 R 3 , —NH—CO 2 R 2 , —NHCO—R 2 or —OCO—NR 2 R 3 ; in which formulae R 2 and R 3 independently of each another represents hydrogen or alkyl; any of its enantiomers or any mixture of enantiomers, or a pharmaceutically acceptable salt thereof.